← Leaderboards
Robert B Banzett
Harvard University (Sch Of Public Hlth)
$9,414,164
Attributed
$9,414,164
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $980.3K · FY2005–17$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$9,414,164 · 4
By mechanism
R01$9,414,164 · 4
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Symptoms”
- Randall J Bateman · Washington University$155,860,406
- Judith S Hochman · New York University School Of Medicine$111,581,511
- Jan C Buckner · Mayo Clinic Coll Of Medicine, Rochester$98,224,091
- Eric Martin McDade · Washington University$96,219,353
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
- Monica M Bertagnolli · Strang Cancer Prevention Center$85,994,687
Research focus
SymptomsShortness Of BreathLaboratoriesDyspneaResponseSensoryClinical ResearchEvaluationMeasurementPainEsthesiaQuestionnairesHospitalsPrevalenceReportingNursesMedicalDistressDimensionsEmotionalDiagnosisChronic Obstructive Airway DiseaseHungerPhysicians
Grant awards (23)
Quantifying a Vital Symptom: Large-scale Inpatient Dyspnea Measurement$174,000
R01 · FY2017 · NR · contact PI
Quantifying a Vital Symptom: Large-scale Inpatient Dyspnea Measurement$49,813
R01 · FY2016 · NR · contact PI
AEROSOL FUROSEMIDE FOR DYSPNEA RELIEF: LABORATORY AND CLINICAL STUDIES$431,269
R01 · FY2015 · NR · contact PI
Quantifying a Vital Symptom: Large-scale Inpatient Dyspnea Measurement$421,950
R01 · FY2015 · NR · contact PI
AEROSOL FUROSEMIDE FOR DYSPNEA RELIEF: LABORATORY AND CLINICAL STUDIES$441,508
R01 · FY2014 · NR · contact PI
Quantifying a Vital Symptom: Large-scale Inpatient Dyspnea Measurement$430,650
R01 · FY2014 · NR · contact PI
Quantifying a Vital Symptom: Large-scale Inpatient Dyspnea Measurement$435,000
R01 · FY2013 · NR · contact PI
AEROSOL FUROSEMIDE FOR DYSPNEA RELIEF: LABORATORY AND CLINICAL STUDIES$434,128
R01 · FY2013 · NR · contact PI
AEROSOL FUROSEMIDE FOR DYSPNEA RELIEF: LABORATORY AND CLINICAL STUDIES$483,893
R01 · FY2012 · NR · contact PI
Investigation of the Affective Dimension of Dyspnea$495,474
R01 · FY2011 · NR · contact PI
AEROSOL FUROSEMIDE FOR DYSPNEA RELIEF: LABORATORY AND CLINICAL STUDIES$484,782
R01 · FY2011 · NR · contact PI
Investigation of the Affective Dimension of Dyspnea$516,453
R01 · FY2010 · NR · contact PI
Investigation of the Affective Dimension of Dyspnea$516,059
R01 · FY2009 · NR · contact PI
Investigation of the Affective Dimension of Dyspnea$508,232
R01 · FY2008 · NR · contact PI
Investigation of the Affective Dimension of Dyspnea$500,667
R01 · FY2007 · NR · contact PI
Cerebral Mechanisms Underlying Dyspnea$394,829
R01 · FY2007 · HL · contact PI
Cerebral Mechanisms Underlying Dyspnea$329,759
R01 · FY2006 · HL · contact PI
Cerebral Mechanisms Underlying Dyspnea$366,620
R01 · FY2005 · HL
CEREBRAL MECHANISMS UNDERLYING DYSPNEA$423,940
R01 · FY2004 · HL
CEREBRAL MECHANISMS UNDERLYING DYSPNEA$412,959
R01 · FY2003 · HL
CEREBRAL MECHANISMS UNDERLYING DYSPNEA$421,844
R01 · FY2002 · HL
CEREBRAL MECHANISMS UNDERLYING DYSPNEA$436,768
R01 · FY2001 · HL
VAGAL AFFERENTS--SENSATIONS ARISING FROM THE LUNG$303,567
R01 · FY2000 · HL